TargetAlpha-2C adrenergic receptor(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Affinity DataKi: 370nMAssay Description:Ability to displace [3H]rauwolscine from cloned human Alpha-2C adrenergic receptorMore data for this Ligand-Target Pair
TargetAlpha-2C adrenergic receptor(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Affinity DataKi: 372nMAssay Description:Binding affinity assayed by displacement of [3H]rauwolscine from human alpha-2C adrenergic receptorMore data for this Ligand-Target Pair
TargetAlpha-2C adrenergic receptor(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Affinity DataKi: 460nMAssay Description:Ability to displace [3H]rauwolscine from cloned human Alpha-2C adrenergic receptorMore data for this Ligand-Target Pair
TargetAlpha-2C adrenergic receptor(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Affinity DataKi: 912nMAssay Description:Binding affinity against human Alpha-2c adrenergic receptorMore data for this Ligand-Target Pair
TargetAlpha-2C adrenergic receptor(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Synaptic Pharmaceutical Corporation
Curated by ChEMBL
Affinity DataKi: 1.32E+3nMAssay Description:Inhibition of [3H]rauwolscine to CHO cells expressing the human Alpha-2C adrenergic receptorMore data for this Ligand-Target Pair